2024 BioSpark Annual Meeting rescheduled to September 14th
汇聚群英智慧，闪亮你我星光
Together, Spark Biomedicine!
Dear All,
The BioSpark team received overwhelming interest from the biotech community after the announcement of a planned annual meeting. We are grateful for the large number of potential attendees and high-profile guest speakers that greatly exceeds our expectations,as well as the sponsors who supported this event.
In order to deliver a high qualify conference by accommodating the availability of many key speakers and a large group of general attendees, we decided to reschedule the annual conference to the following:
Final date: September 14th, Saturday, 2024(EST)
Location: Cambridge, MA
We look forward to seeing you at the BioSpark Annual Conference.
Sincerely,
The BioSpark Team
Conference Background
The ripping effect of high interest rates and tightening monetary policy by Federal Reserve started to manifest in the pharmaceutical industry. Depressed stock price and difficulties in financing posed challenges to biotech companies. Many small- and medium-sized companies rushed to cut expenses, downsize workforces and trim pipelines, hoping to extend their lifelines. But even in this biotech winter, innovations and breakthroughs continue to appear. Companies with stellar clinical data always shine, reminding Wall Street and investors that unmet medical needs are the North Star for biotech to navigate through ups and downs.
Biotech companies with good assets and a tumbling price start to look like a bargain. It does not take long for cash-rich big pharma to go on a shopping spree, leading to a spike in merger and acquisition activities. Meanwhile, transformative innovations in China are beginning to make an impact. A surge of multinational companies entering the Chinese market out-licensing Chinese innovative pipeline assets. The market's expectation for a Federal Reserve interest rate cut in 2024 may imply a subtle but favorable shift in the prospects of the industry.
On September 14, 2024, BioSpark will host the first Annual Conference in Boston. This symposium will gather industry leaders, researchers, investors, and entrepreneurs from the global biotechnology sector. Reflect beyond headlines and decipher underlying forces that shape our industry. The annual conference aims to uncover underlying logic and rationale behind the latest developments in the biopharmaceutical industry. Through keynote presentations, in-depth discussions of industry news, fireside discussions, we will explore development opportunities for the biotech industry.
We sincerely invite you to join us and obtain insights that may help shape research strategy and business development of your organization. Together, let us embrace the reality and upcoming opportunities in the biotech/pharma sector.
Conference Agenda
This symposium expects to gather 200-300 (local) and >10,000 (online) industry leaders, researchers, investors, and entrepreneurs from the global biotechnology sector. Standing in the biotech winter, we will reflect beyond headlines and decipher underlying forces that shape our industry.
FEATURE SESSIONS
BioSpark Annual Biotech News Review
Cancer Immunotherapy, Immunology and Inflammatory Diseases
RNA Targeting Drug Discovery
Precision Medicine in Oncology and CNS Diseases
AI in Drug Discovery and Development
Cross-Boarder BD in 2024: What is the Next Wave?
SPEAKERS
Guoping Feng, Professor
Member of the National Academy of Sciences, MIT (Keynote)
Bo Wang, Assistant Professor
University of Toronto (AI Application)
Chong Xu, Partner
F-prime Capital (VC & BD)
Frank Fan, Founder & CEO
WonderCell Tx (Immunology)
Frank Stegmeier, CSO Partner
Curie.Bio (Precision Medicine)
Isabel Aznarez, Co-founder and SVP of Research
Stoke Tx (RNA targeting)
Jeff Kutok, CSO
Ensem Tx (AI Application)
Jonathan Dry, VP of R&D
Tempus Labs (Precision Medicine)
Leon Tang, Founding partner
ISWT BioAdvisory (VC & BD)
Lizabeth Leveille, VP of BD&L
Merck (VC & BD)
Xianbo Zhou, Co-founder and CEO
Astraneura (Precision Medicine)
More speakers to be confirmed…
Details of the conference agenda and guest list will be released. Please stay tuned!
Conference Partners
Organizer
Co-organizer
Sponsor
Contact us
Prospective sponsors are encouraged to contact the conference affairs team via email as soon as possible to inquire about sponsorship process:
sponsorship@biospark.org
Volunteer/media cooperation/conference consultation：info@biospark.org
About us
BioSpark
BioSpark Group成立于2019年8月，是在美国麻省注册的非盈利机构。BioSpark致力于推动生命科学领域的高级人才交流，建立富有合作和互助精神的社群生态环境，实现学术和企业的跨界交流及思想碰撞，从而帮助华人科学家在世界生物医药领域提升领导力、开拓企业家精神及促进科学发现的商业转化。
BioSpark Group is a non-profit corporation registered in Massachusetts of the United States. The purpose of BioSpark Group is to establish a biotechnology ecosystem with a collaborative and supportive scholar network, promote leadership and entrepreneurship, and facilitate scientific translation.
成为BioSpark会员：BioSpark期待您的加入--会员推荐与申请
Follow us on Twitter:
https://twitter.com/BioSpark_Group
Follow us on LinkedIn:
https://www.linkedin.com/company/biospark-group
BioSpark events Calendar:
https://tinyurl.com/tcwy44t6
Email us: info@BioSpark.org
合作或加入日常活动交流群，请添加小助手微信号：BioSpark-Group
赞 助 机 构
战 略 合 作
BioSpark Group致力于建立华人在生物医领域的生态系统和互助网络，立足于波士顿，我们在硅谷和中国与LEAP Initiative、Dahshu和医药笔记达成战略合作。
更多精彩，请关注BioSpark公众号